Evercore ISI initiated coverage on Omada Health with a new price target
$OMDA
Medical/Nursing Services
Health Care
Evercore ISI initiated coverage of Omada Health with a rating of Outperform and set a new price target of $21.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/14/2026 | $18.00 | Mkt Outperform | Citizens |
| 1/9/2026 | $17.00 | Equal Weight | Wells Fargo |
| 11/13/2025 | $27.00 | Outperform | BMO Capital Markets |
| 9/5/2025 | $24.00 | Neutral | Robert W. Baird |
| 7/1/2025 | $21.00 | Outperform | Evercore ISI |
| 7/1/2025 | $25.00 | Overweight | Morgan Stanley |
| 7/1/2025 | $19.00 | Overweight | Analyst |
| 7/1/2025 | $23.00 | Buy | Needham |
4 - Omada Health, Inc. (0001611115) (Issuer)
4 - Omada Health, Inc. (0001611115) (Issuer)
4 - Omada Health, Inc. (0001611115) (Issuer)
SCHEDULE 13G/A - Omada Health, Inc. (0001611115) (Subject)
10-Q - Omada Health, Inc. (0001611115) (Filer)
8-K - Omada Health, Inc. (0001611115) (Filer)
SAN FRANCISCO, May 27, 2026 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026, taking place in Miami, including a fireside chat on Wednesday, June 10, at 8:20 a.m. PST. The webcast will be available online at https://investors.omadahealth.com/news-events/events. A replay will also be available at the same link following the event. About Omada Health Omada Health (NASDAQ:OMDA) is reverse engineering the way healthcare is delivered in America, putting the space between doctor visits–where health is won or lost–at
SAN FRANCISCO, May 07, 2026 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA) announced it will serve as an independent program administrator in Eli Lilly and Company's Employer Connect program. Omada will offer its GLP‑1 Care Track, including clinical evaluation, prescribing, and ongoing medication management, to employers. This adds a new direct‑to‑employer channel alongside Omada's existing pharmacy benefit manager and cash‑pay pathways to make it easier for employers to offer weight loss medications with coordinated lifestyle support. Integrating with Lilly's Employer Connect allows Omada to provide another option with transparent net cost for Zepbound® and enables defined contribution l
Revenue up 42% Year over Year; Total Members Surpass One Million;Expanded Channels Now Include All Three of the Nation's Leading PBMs SAN FRANCISCO, May 07, 2026 (GLOBE NEWSWIRE) -- Omada Health, Inc. (NASDAQ:OMDA), the virtual between-visit healthcare provider, today reported financial results for the first quarter ended March 31, 2026. Recent Highlights Total Members: 1.02 million Total Members at the end of Q1, up 51% year over year, reinforcing Omada's role as an integrated, multi-condition cardiometabolic platform operating at scale.Revenue: $78 million in the first quarter, up 42% year over year.Omada joined Optum Rx's Weight Engage portfolio to help employers expand responsible,
Citizens initiated coverage of Omada Health with a rating of Mkt Outperform and set a new price target of $18.00
Wells Fargo initiated coverage of Omada Health with a rating of Equal Weight and set a new price target of $17.00
BMO Capital Markets initiated coverage of Omada Health with a rating of Outperform and set a new price target of $27.00
SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, announced it will present two posters at ObesityWeek 2025 highlighting the potential impact of Omada's behavior change program on members currently or previously on GLP-1 medications for weight loss. Together, these analyses suggest that engagement with Omada may enhance results for members who have been on GLP-1s for weight loss, whether they stay on the medication or not. Previous clinical studies have suggested that sustained weight loss leads to increased long-term health benefits,¹ including the reduction of comorbidities, and persistence on a GLP-1 is associate
SAN FRANCISCO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, today announced the appointment of Thomas Tsang, MD, MPH as Chief Medical Officer. Dr. Tsang brings extensive experience in academia, clinical care delivery, and health information technology. In this role, he will lead Omada's clinical organization while advancing clinical quality, outcomes, strategy, and innovation across Omada's multi-condition platform. "Dr. Tsang's exceptional track record in building a virtual care delivery platform makes him the ideal clinical leader to help drive Omada's next phase of growth," said Sean Duffy, CEO and Co-Founder of Omada Heal
The approach defies the restrictive weight loss paradigm, with early results indicating increased meal tracking and member engagement1 with new real-time, personalized nutrition guidance SAN FRANCISCO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, launches Meal Map, a new nutrient-categorization tool that combines AI-powered instant feedback with human care teams to help members in its cardiometabolic programs understand the nutrient quality of their food choices. Built within Omada's Nutritional Intelligence capability, Meal Map is designed to help members make informed food choices, with an aim towards fostering confidence a
Revenue up 42% Year over Year; Total Members Surpass One Million;Expanded Channels Now Include All Three of the Nation's Leading PBMs SAN FRANCISCO, May 07, 2026 (GLOBE NEWSWIRE) -- Omada Health, Inc. (NASDAQ:OMDA), the virtual between-visit healthcare provider, today reported financial results for the first quarter ended March 31, 2026. Recent Highlights Total Members: 1.02 million Total Members at the end of Q1, up 51% year over year, reinforcing Omada's role as an integrated, multi-condition cardiometabolic platform operating at scale.Revenue: $78 million in the first quarter, up 42% year over year.Omada joined Optum Rx's Weight Engage portfolio to help employers expand responsible,
SAN FRANCISCO, April 16, 2026 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, today announced that it will release its first quarter 2026 results on Thursday, May 7, 2026, after market close, and host a conference call to review the results at 4:30 pm ET the same day. Conference Call Details A live audio webcast of the call will be available online at https://investors.omadahealth.com. A replay will be available shortly after the conclusion of the call at the same link and will remain accessible for approximately 12 months. Those participating via conference call can pre-register using the following link: https://register-conf.media-server
SAN FRANCISCO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, today announced that it will release its fourth quarter and full year 2025 results on Thursday, March 5, 2026, after market close, and host a conference call to review the results at 4:30 pm ET the same day. Conference Call Details A live audio webcast of the call will be available online at https://investors.omadahealth.com. A replay will be available shortly after the conclusion of the call at the same link and will remain accessible for approximately 12 months. Those participating via conference call can pre-register using the following link: https://register-c